Rovia Clinical Research Expands Network with New Mississippi Site Partnership
Key Insights
Rovia Clinical Research (search) has launched a new dedicated clinical research site at the Hattiesburg Clinic (search) in Mississippi, partnering with Dr. Rambod Rouhbakhsh as principal investigator.
The partnership extends Rovia's network into an underserved geographic region, leveraging the Hattiesburg Clinic (search)'s position as Mississippi's largest privately-owned multi-specialty health system with over 450 physicians.
This expansion enhances Rovia's capabilities across key therapeutic areas including endocrinology, obesity, cardiology, gastroenterology, neurology, ophthalmology and infectious disease research.
Rovia Clinical Research (search) announced the launch of a new dedicated clinical research site at the Hattiesburg Clinic (search) in Mississippi, marking the company's expansion into an underserved major geographic region. The partnership, established with principal investigator Dr. Rambod Rouhbakhsh, represents a strategic move to enhance clinical trial access in the southeastern United States.
Strategic Partnership Details
The Hattiesburg Clinic (search) serves as Mississippi's largest privately-owned, multi-specialty health system, encompassing more than 450 physicians and providers who serve patients across 17 counties with approximately 2,000 staff members. Dr. Rouhbakhsh brings specialized expertise in family medicine and occupational and environmental medicine, while also serving as program director of the Forrest General Hospital (search) Family Medicine Residency Program.
"The Hattiesburg Clinic (search) and Dr. Rouhbakhsh are highly respected in the region and nation, and we are thrilled to partner with them to launch this new site in an underserved, major geographic region," said Patricio Casillas, CEO of Rovia Clinical Research (search).
Network Expansion Impact
This partnership extends Rovia's footprint into Mississippi while reinforcing the company's patient-centric mission to advance clinical research. The expansion enhances Rovia's capabilities across key therapeutic areas, building upon the network's established focus on endocrinology, obesity, cardiology, gastroenterology, neurology, ophthalmology and infectious disease research.
Rovia's Clinical Research Infrastructure
Rovia Clinical Research (search) operates as a multi-specialty clinical research site network with over 18 years of experience in facilitating clinical trial delivery. The company maintains a hybrid model combining free-standing and physician-embedded sites across its network of 15 sites and more than 80 investigators.
The network has established a track record of exceptional service levels, including rapid study start-up, enrollment target achievement, high patient retention rates and strong data quality. These capabilities have positioned Rovia as a preferred partner for leading global pharmaceutical and biotechnology companies.
Focus on Underserved Communities
The Mississippi expansion aligns with Rovia's broader strategy of fostering collaboration among diverse healthcare stakeholders while prioritizing access for underserved communities. The company leverages centralized teams combined with local market knowledge to implement optimized approaches to trial management and patient engagement.
This geographic expansion into Mississippi addresses a critical need for clinical research infrastructure in the region, potentially improving access to innovative treatments for patients who previously had limited opportunities to participate in clinical trials.